Curis Inc

CRISNASDAQUSD
0.64 USD
0.02 (3.57%)🟢LIVE (AS OF 11:12 AM EDT)
🟢Market: OPEN
Open?$0.63
High?$0.68
Low?$0.60
Prev. Close?$0.62
Volume?313.9K
Avg. Volume?391.4K
VWAP?$0.63
Rel. Volume?0.80x
Bid / Ask
Bid?$0.58 × 100
Ask?$0.61 × 1.0K
Spread?$0.03
Midpoint?$0.60
Valuation & Ratios
Market Cap?24.8M
Shares Out?40.0M
Float?12.7M
Float %?92.2%
P/E Ratio?N/A
P/B Ratio?4.54
EPS?-$0.19
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.49Weak
Quick Ratio?0.49Weak
Cash Ratio?0.36Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
92/100
P/E?
N/A
P/B?
4.54FAIR
P/S?
2.62CHEAP
P/FCF?
N/A
EV/EBITDA?
-3.6CHEAP
EV/Sales?
2.09CHEAP
Returns & Efficiency
ROE?
-138.8%WEAK
ROA?
-38.0%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$19.7M
Related Companies
Loading...
News
Profile
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Employees
24
Market Cap
20.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2000-08-01
Address
128 SPRING STREET
LEXINGTON, MA 02421
Phone: 617-503-6500